找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Uremic Toxins and Organ Failure; Hideyuki Saito,Takaaki Abe Book 2020 Springer Nature Singapore Pte Ltd. 2020 Uremic toxins.Gut microbiome

[復制鏈接]
樓主: CANTO
11#
發(fā)表于 2025-3-23 10:33:06 | 只看該作者
12#
發(fā)表于 2025-3-23 17:56:51 | 只看該作者
Uremic Toxicity and Bone in CKD,ease that predisposes these patients to increase fracture risk is a serious issue. However, bone disease in CKD is a complex disorder and not completely elucidated. Uremia-related bone abnormalities, or bone fragility, have even more complicated pathological processes. We review the current literatu
13#
發(fā)表于 2025-3-23 20:45:58 | 只看該作者
14#
發(fā)表于 2025-3-23 22:16:58 | 只看該作者
Uremic Solutes and Sarcopenia,lecular mechanisms of muscle atrophy in CKD. A persistent imbalance between protein synthesis and degradation causes a loss of muscle mass. A decrease in insulin/IGF-1-Akt-mTOR signaling and an increased ubiquitin–proteasome system have emerged as inducers of muscle loss. During muscle wasting, abno
15#
發(fā)表于 2025-3-24 03:59:51 | 只看該作者
16#
發(fā)表于 2025-3-24 09:52:42 | 只看該作者
17#
發(fā)表于 2025-3-24 10:43:47 | 只看該作者
Book 2020ure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic i
18#
發(fā)表于 2025-3-24 18:02:36 | 只看該作者
Overview of Uremic Toxins,mplications such as cardiovascular disease, bone disease, and sarcopenia. Mass spectrometry has been successfully applied to identify and quantify the uremic toxins in the uremic blood and tissues, and have enabled the identification of novel uremic toxins, and elucidated their role in the uremic complications.
19#
發(fā)表于 2025-3-24 19:14:05 | 只看該作者
Hideyuki Saito,Takaaki AbeProvides detailed descriptions of toxico-pathological mechanisms.Presents the latest research on the gut-kidney axis.Describes a new therapeutic strategy for CKD.Includes special chapters in indoxyl s
20#
發(fā)表于 2025-3-25 00:45:34 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 22:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
岢岚县| 农安县| 浦县| 尚志市| 阳新县| 浮山县| 南乐县| 新巴尔虎右旗| 常州市| 满城县| 波密县| 阳东县| 新和县| 巴中市| 荃湾区| 文安县| 濮阳县| 双牌县| 八宿县| 靖边县| 泾源县| 金塔县| 锡林浩特市| 仙桃市| 鲁山县| 阳新县| 孙吴县| 新乡县| 泰兴市| 永和县| 杭锦后旗| 都安| 澄城县| 凭祥市| 寻乌县| 瑞金市| 沽源县| 保山市| 泰安市| 定结县| 松溪县|